Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), bought 25 shares at $174.54 ($4K) on 2026-03-03, disclosed to the SEC on 2026-03-04.
Open-market purchase of $4k CRL by EVP, Corporate Strategy & Develop. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |
| CRL | SELL | 2025-02-21 | $715K | — | Filing → |